Showing results (581-590 of 790) with videos related to
Sort By:
Pageof 79
Plos One|October 24, 2018
Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinomaHeike Zabeck, Hendrik Dienemann, Hans Hoffmann, et al.The Journal of Clinical Endocrinology and Metabolism|September 17, 2013
a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type IIISilvia Monticone, Namita G Hattangady, David Penton, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 19, 2010
Lipid droplet-associated PAT-proteins show frequent and differential expression in neoplastic steatogenesisBeate K Straub, Esther Herpel, Stephan Singer, et al.Pancreas|November 26, 2014
Ataxia-telangiectasia-mutated protein kinase levels stratify patients with pancreatic adenocarcinoma into prognostic subgroups with loss being a strong indicator of poor survivalCarsten Kamphues, Roberta Bova, Marcus Bahra, et al.The European Respiratory Journal|October 13, 2012
Characteristics and outcome of patients with second primary lung cancerNiels Reinmuth, Andreas Stumpf, Patrick Stumpf, et al.The Journal of Physiology|December 8, 2004
Heteromeric KCNE2/KCNQ1 potassium channels in the luminal membrane of gastric parietal cellsDirk Heitzmann, Florian Grahammer, Thomas von Hahn, et al.The American Journal of Surgical Pathology|November 27, 2018
Tumor Budding and Cell Nest Size Are Highly Prognostic in Laryngeal and Hypopharyngeal Squamous Cell Carcinoma: Further Evidence for a Unified Histopathologic Grading System for Squamous Cell Carcinomas of the Upper Aerodigestive TractMelanie Boxberg, Peer-Hendrik Kuhn, Marianne Reiser, et al.Diagnostic Pathology|November 20, 2016
Next-generation sequencing facilitates detection of the classic E13-A20 EML4-ALK fusion in an ALK-FISH/IHC inconclusive biopsy of a stage IV lung cancer patient: a case reportAnna-Lena Volckmar, Volker Endris, Farastuk Bozorgmehr, et al.Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
The combination of the blood based tumor biomarkers cytokeratin 19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) as a potential predictor of benefit from adjuvant chemotherapy in early stage squamous cell carcinoma of the lung (SCC)Thomas Muley, Vinzent Rolny, Ying He, et al.Journal for Immunotherapy of Cancer|November 21, 2020
Efficacy and immune-related adverse event associations in avelumab-treated patientsKaren Kelly, Juliane Manitz, Manish R Patel, et al.Pageof 79